Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Manipulation of CD98 resolves type 1 diabetes in nonobese diabetic mice.

Lian G, Arimochi H, Kitamura A, Nishida J, Li S, Kishihara K, Maekawa Y, Yasutomo K.

J Immunol. 2012 Mar 1;188(5):2227-34. doi: 10.4049/jimmunol.1102586. Epub 2012 Jan 30.

2.
3.

Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.

Chen C, Lee WH, Yun P, Snow P, Liu CP.

J Immunol. 2003 Jul 15;171(2):733-44.

4.
5.

Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

Transplantation. 2004 Apr 15;77(7):990-7.

PMID:
15087759
6.

CD98hc regulates the development of experimental colitis by controlling effector and regulatory CD4(+) T cells.

Bhuyan ZA, Arimochi H, Nishida J, Kataoka K, Kurihara T, Ishifune C, Tsumura H, Ito M, Ito Y, Kitamura A, Yasutomo K.

Biochem Biophys Res Commun. 2014 Feb 21;444(4):628-33. doi: 10.1016/j.bbrc.2014.01.144. Epub 2014 Jan 31.

PMID:
24491544
7.

Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

Gregori S, Giarratana N, Smiroldo S, Adorini L.

J Immunol. 2003 Oct 15;171(8):4040-7.

8.

Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells.

Liu Z, Hou J, Chen J, Tsumura H, Ito M, Ito Y, Hu X, Li XK.

Transplantation. 2012 Jun 15;93(11):1116-24. doi: 10.1097/TP.0b013e31824fd7cd.

PMID:
22588539
9.

Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P.

J Exp Med. 1997 Nov 17;186(10):1663-76.

10.

CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

Martinez X, Kreuwel HT, Redmond WL, Trenney R, Hunter K, Rosen H, Sarvetnick N, Wicker LS, Sherman LA.

J Immunol. 2005 Aug 1;175(3):1677-85.

11.

Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14580-5. Epub 2004 Aug 30.

13.

B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.

Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, Pop SM, Tisch RM, Tedder TF.

J Immunol. 2008 Mar 1;180(5):2863-75.

17.

A novel function of islet-derived CD8+T cells in initiating and developing autoimmune insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.

Amano K, Yokono K, Hasegawa Y, Taki T, Tominaga Y, Yoneda R, Nagata M, Kasuga M.

Diabetes Res Clin Pract. 1995 Jun;28(3):161-72.

PMID:
8529494
19.

MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.

Serreze DV, Holl TM, Marron MP, Graser RT, Johnson EA, Choisy-Rossi C, Slattery RM, Lieberman SM, DiLorenzo TP.

J Immunol. 2004 Jan 15;172(2):871-9.

Supplemental Content

Support Center